ConductScience.org, home

Paper30469331

Selective Inhibition of Human AKR1B10 by n-Humulone, Adhumulone and Cohumulone Isolated from Humulus lupulus Extract.

Seliger JM and 5 others. Molecules, 2018. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Selective Inhibition of Human AKR1B10 by n-Humulone, Adhumulone and Cohumulone Isolated from Humulus lupulus Extract. Papers, record 30469331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30469331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Selective Inhibition of Human AKR1B10 by n-Humulone, Adhumulone and Cohumulone Isolated from Humulus lupulus Extract.
PubMed
Journal
Molecules
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.81
iCite
Revised in PubMed
2023-10-04
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Seliger JMJan Moritzhttps://orcid.org/0000-0003-1337-2850
2Cicek SSSerhat Sezaihttps://orcid.org/0000-0002-3038-8523
3Witt LTLydia T
4Martin HJHans-Jörg
5Maser EEdmund
6Hintzpeter JJan

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aldehyde ReductaseMajor topic
CyclohexanonesMajor topic
CyclohexenesMajor topic
TerpenesMajor topic
Aldo-Keto Reductases
Drug Evaluation, Preclinical
Drug Screening Assays, Antitumor
Farnesol
Gene Expression Regulation, Enzymologic
Humans
Humulus

Source PubMed

Download CSV of topics

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117597105Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention.Int J Cancer2007https://conductscience.org/library/papers/17597105PubMed
227665999Inhibition of aldo-keto reductase family 1 member B10 by unsaturated fatty acids.Arch Biochem Biophys2016https://conductscience.org/library/papers/27665999PubMed
328554840Atorvastatin augments temozolomide's efficacy in glioblastoma via prenylation-dependent inhibition of Ras signaling.Biochem Biophys Res Commun2017https://conductscience.org/library/papers/28554840PubMed
418788756Oxidation of PAH trans-dihydrodiols by human aldo-keto reductase AKR1B10.Chem Res Toxicol2008https://conductscience.org/library/papers/18788756PubMed
519464995Kinetic studies of AKR1B10, human aldose reductase-like protein: endogenous substrates and inhibition by steroids.Arch Biochem Biophys2009https://conductscience.org/library/papers/19464995PubMed
629532688The hop-derived compounds xanthohumol, isoxanthohumol and 8-prenylnaringenin are tight-binding inhibitors of human aldo-keto reductases 1B1 and 1B10.J Enzyme Inhib Med Chem2018https://conductscience.org/library/papers/29532688PubMed
721187079Roles of rat and human aldo-keto reductases in metabolism of farnesol and geranylgeraniol.Chem Biol Interact2011https://conductscience.org/library/papers/21187079PubMed
826844556Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment.Recent Pat Anticancer Drug Discov2016https://conductscience.org/library/papers/26844556PubMed
915953717Beer constituents as potential cancer chemopreventive agents.Eur J Cancer2005https://conductscience.org/library/papers/15953717PubMed
108024813Lipid modifications of G proteins.Curr Opin Cell Biol1994https://conductscience.org/library/papers/8024813PubMed
1122222635Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma.Mod Pathol2012https://conductscience.org/library/papers/22222635PubMed
1222710979Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression.Oncol Rep2012https://conductscience.org/library/papers/22710979PubMed
1310631313Suppression of cyclooxygenase-2 gene transcription by humulon of beer hop extract studied with reference to glucocorticoid.FEBS Lett2000https://conductscience.org/library/papers/10631313PubMed
1411708802Inhibition of angiogenesis by humulone, a bitter acid from beer hop.Biochem Biophys Res Commun2001https://conductscience.org/library/papers/11708802PubMed
1524088726Deeper insight into the reducing biotransformation of bupropion in the human liver.Drug Metab Pharmacokinet2014https://conductscience.org/library/papers/24088726PubMed
1616381663Purification and characterization of akr1b10 from human liver: role in carbonyl reduction of xenobiotics.Drug Metab Dispos2006https://conductscience.org/library/papers/16381663PubMed
1727855345Overexpression and enhanced specific activity of aldoketo reductases (AKR1B1 & AKR1B10) in human breast cancers.Breast2017https://conductscience.org/library/papers/27855345PubMed
1819655312Hop bitter acids efficiently block inflammation independent of GRalpha, PPARalpha, or PPARgamma.Mol Nutr Food Res2009https://conductscience.org/library/papers/19655312PubMed
1919014918Aldo-keto reductases from the AKR1B subfamily: retinoid specificity and control of cellular retinoic acid levels.Chem Biol Interact2009https://conductscience.org/library/papers/19014918PubMed
2023790907Simultaneous determination of prenylflavonoid and hop bitter acid in beer lee by HPLC-DAD-MS.Food Chem2013https://conductscience.org/library/papers/23790907PubMed

See all 38 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
41226644Integrated Molecular and Functional Analysis of Hop Ethanolic Extract in Caco-2 Cells: Insights into Inflammation, Barrier Function, and Transport.Int J Mol Sci2025https://conductscience.org/library/papers/41226644PubMed
37681045Inhibitory selectivity to the AKR1B10 and aldose reductase (AR): insight from molecular dynamics simulations and free energy calculations.RSC Adv2023https://conductscience.org/library/papers/37681045PubMed
36364156Chemical Profiling and Biological Activity of Extracts from Nine Norwegian Medicinal and Aromatic Plants.Molecules2022https://conductscience.org/library/papers/36364156PubMed
34552036AKR1B10 inhibits the proliferation and migration of gastric cancer via regulating epithelial-mesenchymal transition.Aging (Albany NY)2021https://conductscience.org/library/papers/34552036PubMed
34063865The Role of AKR1B10 in Physiology and Pathophysiology.Metabolites2021https://conductscience.org/library/papers/34063865PubMed
32859627Whole-transcriptome Analysis of Fully Viable Energy Efficient Glycolytic-null Cancer Cells Established by Double Genetic Knockout of Lactate Dehydrogenase A/B or Glucose-6-Phosphate Isomerase.Cancer Genomics Proteomics2020https://conductscience.org/library/papers/32859627PubMed
31009997Beer Molecules and Its Sensory and Biological Properties: A Review.Molecules2019https://conductscience.org/library/papers/31009997PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30469331

GET https://conductscience.org/api/papers/v1/30469331/references?page=2